Literature DB >> 6801370

Circulating immune complexes in membranoproliferative glomerulonephritis.

C A Davis, H Marder, C D West.   

Abstract

Circulating immune complexes (CIC), measured by the solid-phase Clq method, were found to be in abnormal concentration in about half of 39 patients with membranoproliferative glomerulonephritis (MPGN). In contrast, they were present, usually in higher concentration, in nearly all patients with active lupus nephritis. Correlations between clinical course and CIC levels in patients with MPGN showed that complexes were always present when the disease was mild or "silent," but when renal impairment developed or was incipient, complexes were nearly always absent. In patients with disease of intermediate severity, characterized by definite proteinuria but without renal impairment, 50% had complexes. The presence of complexes when glomerular abnormality is relatively slight could be interpreted as indicating that the complexes measured were not nephritogenic, or that they program subsequent events that augment glomerular injury in the absence of complexes. The measurement of CIC in MPGN appears to have minimal value both in diagnosis and in determining prognosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6801370     DOI: 10.1038/ki.1981.203

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  3 in total

1.  Glomerular injury in end-stage liver disease--role of circulating IgG and IgM immune complexes.

Authors:  L S Milner; M T Houser; P C Kolbeck; D L Antonson; T L McDonald; R S Markin; B W Shaw
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

2.  Inhibition of immune complex solubilization by sera of patients with membranoproliferative glomerulonephritis.

Authors:  T R Welch; A Kleesattel; L Beischel
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

3.  Remission of membranoproliferative glomerulonephritis associated with a noncirrhotic portosystemic shunt after percutaneous transhepatic portal vein embolization.

Authors:  Nobuhiko Okamoto; Sawako Fukazawa; Masafumi Shimamoto; Rie Yamamoto; Yuichiro Fukazawa
Journal:  NDT Plus       Date:  2009-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.